Aflibercept and ranibizumab comparable in macular degeneration

NEW YORK (Reuters Health) – They’re similarly effective and safe for neovascular age-related macular
degeneration, but intravitreal aflibercept might have an edge over ranibizumab in convenience, researchers
say.
Source: Modern Medicine: Optometry